Suppression of collagen-induced arthritis by oral administration of the Citrus flavonoid hesperidin

Planta Medica

Volumn 72, Issue 5, 2006, Pages 477-479

  Kawaguchi, Kiichiro ^a   Maruyama, Hiroko ^a   Kometani, Takashi ^b   Kumazawa, Yoshio ^a  

^a KITASATO UNIVERSITY   (Japan)

^b EZAKI GLICO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOFLAVONOID; CITRUS FRUIT EXTRACT; COLLAGEN; COLLAGEN TYPE 2; FREUND ADJUVANT; HESPERIDIN; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CITRUS FRUIT; CONTROLLED STUDY; DISEASE MODEL; DRUG MECHANISM; HISTOPATHOLOGY; IMMUNIZATION; MOUSE; NONHUMAN; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; CITRUS; COLLAGEN; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HESPERIDIN; KNEE JOINT; MACROPHAGES; MICE; PHYTOTHERAPY; PLANT EXTRACTS; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; CITRUS;

EID: 33645993314     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-916254     Document Type: Article

References (12)

1. Feldmann M, Brennen FM, Chantry D, Haworth C, Turner M, Katsikis P et al. Cytokine assays: role in evaluation of the pathogenesis of autoimmunity. Immunol Rev 1991; 119: 105-23 -
2. Elson CJ, Thompson SJ, Westacott CI, Bhoola KD. Mediators of joint swelling and damage in rheumatoid arthritis and pristane induced arthritis. Autoimmunity 1992; 13: 327-31
3. Klareskog L, McDevitt H. Rheumatoid arthritis and its animal models: the role of TNF-α and the possible absence of specific immune reactions. Curr Opin Immunol 1999; 11: 657-62
4. Chu CQ, Field M, Feldmann M, Maini RN. Localization of tumor necrosis factor a in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991; 34: 1125-32
5. Brahn E, Peacock DJ, Banquerigo ML, Liu DY. Effects of tumor necrosis factor α (TNF-α) on collagen arthritis. Lymphokine Cytokine Res 1992; 11: 253-6
6. Mikuls TR, Weaver AL. Lessons learned in the use of tumor necrosis factor-α inhibitors in the treatment of rheumatoid arthritis. Curr Rheumatol Rep 2003; 5: 270-7
7. Taylor PC. Anti-TNFα therapy for rheumatoid arthritis: an update. Intern Med 2003; 42: 15-20
8. Shanahan JC, St Clair W. Tumor necrosis factor-α blockade: a novel therapy for rheumatic disease. Clin Immunol 2002; 103: 231-42
9. Graninger WB, Smolen JS. One-year inhibition of tumor necrosis factor-α: a major success or a larger puzzle. Curr Opin Rheumatol 2001; 13: 209-13
10. Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 2001; 19: 163-96
11. Kawaguchi K, Kikuchi S, Hasegawa H, Maruyama H, Morita H, Kumazawa Y. Suppression of lipopolysaccharide-induced tumor necrosis factor-release and liver injury in mice by naringin. Eur J Pharmacol 1999; 368: 245-50
12. Kawaguchi K, Kikuchi S, Hasunuma R, Maruyama H, Yoshikawa T, Kumazawa Y. A citrus flavonoid hesperidin suppresses infection-induced endotoxin shock in mice. Biol Pharm Bull 2004; 27: 679-83